EFFICACY OF AN AUTOGENOUS VACCINE AGAINST HIGHLY VIRULENT STAPHYLOCOCCUS AUREUS INFECTION IN RABBITS

被引:5
|
作者
Meulemans, G. [1 ]
Haesebrouck, F. [1 ]
Lipinska, U. [1 ]
Duchateau, L. [2 ]
Hermans, K. [1 ]
机构
[1] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Poultry Diseases, B-9820 Merelbeke, Belgium
[2] Univ Ghent, Fac Vet Med, Dept Physiol & Biometr, B-9820 Merelbeke, Belgium
关键词
Staphylococcus aureus; virulence; infection; rabbit; skin; autovaccine; BOVINE MASTITIS; FIELD TRIALS; STRAINS; BACTERIN; COLONIZATION;
D O I
10.4995/wrs.2011.812
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The efficacy of an autogenous vaccine consisting of a whole cell suspension of formalin killed bacteria in sterile buffered saline against Staphylococcus aureus infections was determined, using a well-established rabbit skin infection model. Thirteen 8 wk old rabbits were vaccinated twice subcutaneously with a 2 wk interval while 10 rabbits were injected twice with formalised PBS (sterile phosphate buffered saline). Two weeks after the last injection, 10 vaccinated and all PBS-injected rabbits were inoculated intradermally with 10(8) cfu of a S. aureus strain (KH 171)which had been shown to be highly virulent for rabbits. Three vaccinated animals served as negative controls and were intradermally injected with sterile buffered saline. All rabbits were examined daily for the development of skin lesions until 14 d after the experimental infection when all rabbits were euthanised. All animals experimentally infected with S. aureus developed skin abscesses within 24 h post-inoculation, but in the vaccinated group the maximum abscess diameter was significantly lower than in the non-vaccinated group (P=0.048). This difference between autovaccinated and non-vaccinated groups increased over time (P < 0.001). These results indicate that vaccination with an inactivated whole cell bacterin may be useful for control of staphylococcosis in rabbits but does not prevent abscess formation in animals inoculated with a high dose of a highly virulent S. aureus strain.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus
    Nohr-Meldgaard, Katrine
    Ovsepian, Armen
    Ingmer, Hanne
    Vestergaard, Martin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (03) : 390 - 396
  • [32] Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis
    Kaatz, GW
    Seo, SM
    Aeschlimann, JR
    Houlihan, HH
    Mercier, RC
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (02) : 254 - 256
  • [33] The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus
    Jahantigh, Hamid Reza
    Faezi, Sobhan
    Habibi, Mehri
    Mahdavi, Mehdi
    Stufano, Angela
    Lovreglio, Piero
    Ahmadi, Khadijeh
    VACCINES, 2022, 10 (02)
  • [34] Design of a multi-epitope vaccine against Staphylococcus aureus
    Jolois, M.
    Taminiau, B.
    Rhazi, N.
    Jacquet, A.
    Heinen, E.
    VACCINE, 2008,
  • [36] Mineralized Bacteria as a Potent Vaccine Against Staphylococcus aureus Infections
    Chen, Xiaojing
    Zhang, Shiyuan
    Wang, Chenya
    Chao, Ting
    Ren, Jiacheng
    Gao, Feng
    Liu, Zhuang
    Peng, Rui
    SMALL, 2025,
  • [37] Recent advances in Staphylococcus aureus infection: focus on vaccine development
    Ansari, Shamshul
    Jha, Rajesh Kumar
    Mishra, Shyam Kumar
    Tiwari, Birendra Raj
    Asaad, Ahmed Morad
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 1243 - 1255
  • [38] The failure of allergic inflammation to protect rabbits against infection with virulent pneumococci
    Cannon, PR
    Hartley, G
    AMERICAN JOURNAL OF PATHOLOGY, 1938, 14 (01): : 87 - U42
  • [40] Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus
    Balaban, N
    Goldkorn, T
    Nhan, RT
    Dang, LB
    Scott, S
    Ridgley, RM
    Rasooly, A
    Wright, SC
    Larrick, JW
    Rasooly, R
    Carlson, JR
    SCIENCE, 1998, 280 (5362) : 438 - 440